Evaluate the safety, tolerability, biodistribution and anti tumour activity of 177Lu-OPS201 with companion imaging 68Ga-OPS202 PET/CT in previously treated subjects with locally advanced or metastatic cancers expressing somatostatin receptor 2 (SSTR2) (SSTR2+). Here, SSTR2 is linked to neoplasm.